PAVmed (PAVM) PT Lowered to $21 at Ascendiant Capital
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
